Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function

Glycoconjugate Journal

Volumn 26, Issue 1, 2009, Pages 3-17

  Singh, Bibhuti N ^a   Hayes, Gary R ^a   Lucas, John J ^a   Sommer, Ulf ^b   Viseux, Nelly ^b   Mirgorodskaya, Ekaterina ^b   Trifonova, Radiana T ^c   Sassi, Rosaria Rita S ^c   Costello, Catherine E ^b   Fichorova, Raina N ^c  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cytokines; ERK; Mass spectrometry; NF B; Trichomonad LPG; Vaginal mucosal immunity

Indexed keywords

BETA GALACTOSIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPHOSPHOGLYCAN; MITOGEN ACTIVATED PROTEIN KINASE 3;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; TRICHOMONAS VAGINALIS;

ANIMALS; CELL LINE, TRANSFORMED; CERVIX UTERI; CHEMOKINES; ENZYME ACTIVATION; EPITHELIAL CELLS; FEMALE; GLYCOSPHINGOLIPIDS; HUMANS; HYDROLYSIS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; VAGINA;

TRICHOMONAS VAGINALIS;

EID: 59449109414     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-008-9157-1     Document Type: Article

References (62)

1. D. Petrin K. Delgaty R. Bhatt G. Garber 1998 Clinical and microbiological aspects of Trichomonas vaginalis Clin. Microbiol. Rev. 11 300 317
2. J.S. Ryu D.Y. Min 2006 Trichomonas vaginalis and trichomoniasis in the Republic of Korea Korean J. Parasitol. 44 101 116
3. J.R. Schwebke 2005 Trichomoniasis in adolescents: a marker for the lack of a public health response to the epidemic of sexually transmitted diseases in the United States J. Infect. Dis. 192 2036 2038
4. J.R. Schwebke D. Burgess 2004 Trichomoniasis Clin. Microbiol. Rev. 17 794 803
5. J.R. Schwebke T. Aira N. Jordan P.E. Jolly S.H. Vermund 1998 Sexually transmitted diseases in Ulaanbaatar, Mongolia Int. J. STD. AIDS. 9 354 358
6. F.J. Bowden B.A. Paterson J. Mein J. Savage C.K. Fairley S.M. Garland S.N. Tabrizi 1999 Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia Sex Transm. Infect. 75 431 434
7. R.O. Gilbert G. Elia D.H. Beach S. Klaessig B.N. Singh 2000 Cytopathogenic effect of Trichomonas vaginalis on human vaginal epithelial cells cultured in vitro Infect. Immun. 68 4200 4206
8. U. Sommer C.E. Costello G.R. Hayes D.H. Beach R.O. Gilbert J.J. Lucas B.N. Singh 2005 Identification of Trichomonas vaginalis cysteine proteases that induce apoptosis in human vaginal epithelial cells J. Biol. Chem. 280 23853 23860
9. J.N. Krieger C. Jenny M. Verdon N. Siegel R. Springwater C.W. Critchlow K.K. Holmes 1993 Clinical manifestations of trichomoniasis in men Ann. Internal. Med. 118 844 849
10. J.N. Krieger M. Verdon N. Siegel K.K. Holmes 1993 Natural history of urogenital trichomoniasis in men J. Urol. 149 1455 1458
11. F. Sorvillo L. Smith P. Kerndt L. Ash 2001 Trichomonas vaginalis, HIV, and African-Americans Emerg. Infect. Dis. 7 927 932
12. H. Weinstock S. Berman W. Cates Jr. 2004 Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000 Perspect. Sex Reprod. Health. 36 6 10
13. R.S. McClelland L. Sangare W.M. Hassan L. Lavreys K. Mandaliya J. Kiarie J. Ndinya-Achola W. Jaoko J.M. Baeten 2007 Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition J. Infect. Dis. 195 698 702
14. L.B. Corbeil C.M. Campero J.C. Rhyan R.H. BonDurant 2003 Vaccines against sexually transmitted diseases Reprod. Biol. Endocrinol. 1 118
15. J.S. Ryu J.H. Kang S.Y. Jung M.H. Shin J.M. Kim H. Park D.Y. Min 2004 Production of interleukin-8 by human neutrophils stimulated with Trichomonas vaginalis Infect. Immun. 72 1326 1332
16. M.F. Shaio P.R. Lin J.Y. Liu K.D. Yang 1995 Generation of interleukin-8 from human monocytes in response to Trichomonas vaginalis stimulation Infect. Immun. 63 3864 3870
17. M.A. Ferguson 1999 The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research J. Cell Sci. 112 Pt 17 2799 2809
18. S.J. Turco A. Descoteaux 1992 The lipophosphoglycan of Leishmania parasites Annu. Rev. Microbiol. 46 65 94
19. R.P.P. Soares T.L. Cardoso T. Barron M.S.S. Araujo P.F.P. Pimenta S.J. Turco 2005 Leishmania braziliensis: a novel mechanism in the lipophosphoglycan regulation during metacyclogenesis Int. J. Parasitol. 35 245 253
20. R. Lodge A. Descoteaux 2005 Modulation of phagolysosome biogenesis by the lipophosphoglycan of Leishmania Clinical Immunology 114 256 265
21. B.N. Singh J.J. Lucas D.H. Beach S.T. Shin R.O. Gilbert 1999 Adhesion of Trichomonas foetus to bovine vaginal epithelial cells Infect. Immun. 67 3847 3854
22. R.N. Fichorova R.T. Trifonova R.O. Gilbert C.E. Costello G.R. Hayes J.J. Lucas B.N. Singh 2006 Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells Infect. Immun. 74 5773 5779
23. B.N. Singh 1993 Lipophosphoglycan-like glycoconjugate of Trichomonas foetus and Trichomonas vaginalis Mol. Biochem. Parasitol. 57 281 294
24. B.N. Singh D.H. Beach D.G. Lindmark C.E. Costello 1994 Identification of the lipid moiety and further characterization of the novel lipophosphoglycan- like glycoconjugates of Trichomonas vaginalis and Trichomonas foetus Arch. Biochem. Biophys. 309 273 280
25. Singh, B.N., Lucas, J.J., Fichorova, R.N.: In: Khan, N.A., Jarrol, E.L. (eds.) Emerging Protozoan Pathogens, pp. 411-455. Taylor & Francis, London (2007)
26. A. Guha-Niyogi D.R. Sullivan S.J. Turco 2001 Glycoconjugate structures of parasitic protozoa Glycobiology. 11 45R 59R
27. B.N. Singh R.H. BonDurant C.M. Campero L.B. Corbeil 2001 Immunological and biochemical analysis of glycosylated surface antigens and lipophosphoglycan of Trichomonas foetus J. Parasitol. 87 770 777
28. F.D. Bastida-Corcuera C.Y. Okumura A. Colocoussi P.J. Johnson 2005 Trichomonas vaginalis lipophosphoglycan mutants have reduced adherence and cytotoxicity to human ectocervical cells Eukaryot. Cell. 4 1951 1958
29. W. Hashimoto O. Miyake H. Nankai K. Murata 2003 Molecular identification of an alpha-l-rhamnosidase from Bacillus sp strain GL1 as an enzyme involved in complete metabolism of gellan Arch. Biochem. Biophys. 415 235 244
30. D.B. Jordan J.D. Braker 2007 Inhibition of the two-subsite beta-d-xylosidase from Selenomonas ruminantium by sugars: competitive, noncompetitive, double binding, and slow binding modes Arch. Biochem. Biophys. 465 231 246
31. N. Viseux C.E. Costello B. Domon 1999 Post-source decay mass spectrometry: optimized calibration procedure and structural characterization of permethylated oligosaccharides J. Mass Spectrom. 34 364 376
32. C.E. Costello J.M. Contado-Miller J.F. Cipollo 2007 A glycomics platform for the analysis of permethylated oligosaccharide alditols J. Am. Soc. Mass Spectrom. 18 1799 1812
33. R.N. Fichorova J.G. Rheinwald D.J. Anderson 1997 Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins Biol. Reprod. 57 847 855
34. R.N. Fichorova F. Zhou V. Ratnam V. Atanassova S. Jiang N. Strick A.R. Neurath 2005 Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation Antimicrob. Agents Chemother. 49 323 335
35. R.N. Fichorova M. Bajpai N. Chandra J.G. Hsiu M. Spangler V. Ratnam G.F. Doncel 2004 Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives Biol. Reprod. 71 761 769
36. G.F. Doncel N. Chandra R.N. Fichorova 2004 Preclinical assessment of the proinflammatory potential of microbicide candidates J. Acquir. Immune. Defic. Syndr. 37 Suppl 3 S174 180
37. R.N. Fichorova A.O. Cronin E. Lien D.J. Anderson R.R. Ingalls 2002 Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling J. Immunol. 168 2424 2432
38. R.N. Fichorova L.D. Tucker D.J. Anderson 2001 The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission J. Infect. Dis. 184 418 428
39. R.N. Fichorova P.J. Desai F.C. Gibson 3rd C.A. Genco 2001 Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells Infect. Immun. 69 5840 5848
40. R.N. Fichorova D.J. Anderson 1999 Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells Biol. Reprod. 60 508 514
41. F.C. Krebs S.R. Miller B.J. Catalone R. Fichorova D. Anderson D. Malamud M.K. Howett B. Wigdahl 2002 Comparative in vitro sensitivities of human immune cell lines, vaginal and cervical epithelial cell lines, and primary cells to candidate microbicides nonoxynol 9, C31G, and sodium dodecyl sulfate Antimicrob. Agents Chemother. 46 2292 2298
42. Z.W. Wu Z.W. Chen D.M. Phillips 2003 Human genital epithelial cells capture cell-free human immunodeficiency virus type 1 and transmit the virus to CD4(+) cells: implications for mechanisms of sexual transmission J. Infect. Dis. 188 1473 1482
43. C. Steele P.L. Fidel Jr. 2002 Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans Infect. Immun. 70 577 583
44. M.M. Barousse C. Steele K. Dunlap T. Espinosa D. Boikov J.D. Sobel P.L. Fidel 2001 Growth inhibition of Candida albicans by human vaginal epithelial cells J. Infect. Dis. 184 1489 1493
45. J. Levin F.B. Bang 1968 Clottable protein in Limulus; its localization and kinetics of its coagulation by endotoxin Thromb. Diath. Haemorrh. 19 186 197
46. R.T. Trifonova J.M. Pasicznyk R.N. Fichorova 2006 Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo Antimicrob. Agents Chemother. 50 4005 4010
47. B.N. Singh J.J. Lucas D.H. Beach C.E. Costello 1994 Expression of a novel cell surface lipophosphoglycan-like glycoconjugate in Trypanosoma cruzi epimastigotes J. Biol. Chem. 269 21972 21982
48. V.N. Reinhold B.B. Reinhold C.E. Costello 1995 Carbohydrate molecular weight profiling, sequence, linkage, and branching data: ES-MS and CID Anal. Chem. 67 1772 1784
49. P. Orlean A.K. Menon 2007 Thematic review series:lipid posttranslational modifications. GPI anchoring of protein in yeast and mammalian cells, or: how we learned to stop worrying and love glycophospholipids J. Lipid Res. 48 993 1011
50. G.A. Rabinovich A. Gruppi 2005 Galectins as immunoregulators during infectious processes: from microbial invasion to the resolution of the disease Parasite. Immunol. 27 103 114
51. J.M. Ilarregui G.A. Bianco M.A. Toscano G.A. Rabinovich 2005 The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders Ann. Rheum. Dis. 64 96 103
52. T.K. van den Berg H. Honing N. Franke A. van Remoortere W.E. Schiphorst F.T. Liu A.M. Deelder R.D. Cummings C.H. Hokke I. van Die 2004 LacdiNAc-glycans constitute a parasite pattern for galectin-3-mediated immune recognition J. Immunol. 173 1902 1907
53. Fichorova, R.N., Trifonova, R.T., Singh, B.N.: T. vaginalis LPG regulates cytokine responses via binding galectins on human vaginal epithelial cells. Microbicides 2008. New Delhi, India, 2008
54. N.D. Perkins 1997 Achieving transcriptional specificity with NF-kB Int. J. Biochem. Cell Biol. 29 1433 1448
55. R.N. Fichorova 2004 Guiding the vaginal microbicide trials with biomarkers of inflammation J. Acquir. Immune. Defic. Syndr. 37 Suppl 3 S184 193
56. S. Cauci S. Guaschino D. De Aloysio S. Driussi D. De Santo P. Penacchioni F. Quadrifoglio 2003 Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women Mol. Hum. Reprod. 9 53 58
57. N. Mukaida 2000 Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation Int. J. Hematol. 72 391 398
58. R. Narimatsu D. Wolday B.K. Patterson 2005 IL-8 increases transmission of HIV type 1 in cervical explant tissue AIDS Res. Hum. Retroviruses. 21 228 233
59. B.R. Lane K. Lore P.J. Bock J. Andersson M.J. Coffey R.M. Strieter D.M. Markovitz 2001 Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy J. Virol. 75 8195 8202
60. S.-M. Oh S.-H. Lee B.-J. Lee C.-W. Pyo N.-K. Yoo S.Y. Lee J. Kim S.-Y. Choi 2007 A distinct role of neutrophil lactoferrin in RelA/p65 phosphorylation on Ser536 by recruiting TNF receptor-associated factors to I{kappa}B kinase signaling complex J. Immunol. 179 5686 5692
61. Y.S. Ryang J.H. Chang J.Y. Park 2004 Involvement of MAP kinases in apoptosis of macrophage treated with Trichomonas vaginalis Yonsei. Med. J. 45 751 754
62. C.M. Crews A. Alessandrini R.L. Erikson 1992 The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product Science 258 478 480